Influence of azithromycin and allograft rejection on the post–lung transplant microbiota
Volume: 39, Issue: 2, Pages: 176 - 183
Published: Feb 1, 2020
Abstract
BACKGROUND Alterations in the lung microbiota may drive disease development and progression in patients with chronic respiratory diseases. Following lung transplantation (LTx), azithromycin is used to both treat and prevent chronic lung allograft dysfunction (CLAD). The objective of this study was to determine the association between azithromycin use, CLAD, acute rejection, airway inflammation, and bacterial microbiota composition and structure...
Paper Details
Title
Influence of azithromycin and allograft rejection on the post–lung transplant microbiota
Published Date
Feb 1, 2020
Volume
39
Issue
2
Pages
176 - 183
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History